Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,097,817 | 1,687,829 | 3,213,376 | 2,951,422 | 2,057,440 |
| Marketable Securities | 482,787 | 470,263 | 442,667 | 287,543 | 290,752 |
| Receivables | 1,024,407 | 853,154 | 743,557 | 644,879 | 616,300 |
| Inventories | 101,060 | 58,872 | 62,972 | 41,995 | 27,904 |
| TOTAL | $5,023,902 | $3,239,030 | $4,645,402 | $4,092,850 | $3,118,674 |
| Non-Current Assets | |||||
| PPE Net | 730,885 | 763,411 | 751,513 | 739,310 | 723,920 |
| Investments And Advances | 47,991 | 18,814 | 187,716 | 133,676 | 221,266 |
| Intangibles | 117,131 | 113,803 | 123,545 | 129,219 | 150,755 |
| Other Non-Current Assets | 1,038,064 | 1,309,264 | 1,073,931 | 745,929 | 718,737 |
| TOTAL | $1,934,071 | $2,205,292 | $2,136,705 | $1,748,134 | $1,814,678 |
| Total Assets | $6,957,973 | $5,444,322 | $6,782,107 | $5,840,984 | $4,933,352 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 209,938 | 197,465 | 109,601 | 277,546 | 172,110 |
| Accrued Expenses | 1,300,716 | 1,439,963 | 1,127,339 | 876,352 | 679,563 |
| TOTAL | $1,515,170 | $1,641,847 | $1,240,379 | $1,157,077 | $854,308 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 245,126 | 321,305 | 322,729 | 283,705 | 277,408 |
| TOTAL | $275,325 | $354,847 | $351,891 | $313,788 | $309,040 |
| Total Liabilities | $1,790,495 | $1,996,694 | $1,592,270 | $1,470,865 | $1,163,348 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 199,015 | 193,524 | 224,526 | 222,965 | 221,325 |
| Common Shares | 198 | 193 | 224 | 223 | 221 |
| Retained earnings | 213,769 | -1,072,881 | 160,385 | -437,214 | -777,874 |
| Other shareholders' equity | 25,462 | -13,121 | 13,106 | 15,069 | -19,454 |
| TOTAL | $5,167,478 | $3,447,628 | $5,189,837 | $4,370,119 | $3,770,004 |
| Total Liabilities And Equity | $6,957,973 | $5,444,322 | $6,782,107 | $5,840,984 | $4,933,352 |